Cardiovascular risk moderates the effect of aerobic exercise on executive functions in older adults with subcortical ischemic vascular cognitive impairment

Cindy K Barha, Elizabeth Dao, Lauren Marcotte, Ging-Yuek Robin Hsiung, Roger Tam, Teresa Liu-Ambrose, Cindy K Barha, Elizabeth Dao, Lauren Marcotte, Ging-Yuek Robin Hsiung, Roger Tam, Teresa Liu-Ambrose

Abstract

Aerobic training (AT) can promote cognitive function in adults with Subcortical Ischemic Vascular Cognitive Impairment (SIVCI) by modifying cardiovascular risk factors. However, pre-existing cardiovascular health may attenuate the benefits of AT on cognitive outcomes in SIVCI. We examined whether baseline cardiovascular risk moderates the effect of a 6-month progressive AT program on executive functions with a secondary analysis of a randomized controlled trial in 71 adults, who were randomized to either: (1) 3×/week progressive AT; or (2) education program (CON). Three executive processes were measured: (1) response inhibition by Stroop Test; (2) working memory by digits backward test; and (3) set shifting by the Trail Making Test. Baseline cardiovascular risk was calculated using the Framingham cardiovascular disease (CVD) Risk Score (FCRS), and participants were classified as either low risk (< 20% FCRS score; LCVR) or high risk (≥ 20% FCRS score; HCVR). A complete case analysis (n = 58) was conducted using an analysis of covariance (ANCOVA) to evaluate between-group differences in the three executive processes. A significant interaction was found between cardiovascular risk group and intervention group (AT or CON) for the digit span backward and the Trail Making Test. AT improved performance compared with CON in those with LCVR, while in those with HCVR, AT did not improve performance compared with CON. Baseline cardiovascular risk significantly moderates the efficacy of AT on cognition. Our findings highlight the importance of intervening early in the disease course of SIVCI, when cardiovascular risk may be lower, to reap maximum benefits of aerobic exercise.

Conflict of interest statement

The authors declare no competing interests.

© 2021. The Author(s).

Figures

Figure 1
Figure 1
Interaction between cardiovascular risk (CVR) group (low CVR, high CVR) and experimental group (control, aerobic training) on the three tests of executive function at trial completion, controlling for baseline performance on the test, age, baseline MoCA score, and education. (A) Estimated mean (+ SEM) total number correct on the Verbal digits backward test at trial completion, with a significant interaction between cardiovascular risk group and experimental group (p < 0.037), suggesting that aerobic training improved the total number of correct responses compared to control in the low CVR participants but not in the high CVR participants. (B) Estimated mean (+ SEM) time to complete the Trail-Making tests (Part B minus Part A; seconds) at trial completion, with a significant interaction between cardiovascular risk group and experimental group (p < 0.048), suggesting that aerobic training improved performance compared to control in the low CVR participants but not in the high CVR participants. (C) Estimated mean (+ SEM) time to complete the Stroop test at trial completion, with no significant interaction between cardiovascular risk group and experimental group (p > 0.819), suggesting that aerobic training not influence performance compared to control in either the low CVR or high CVR participants.

References

    1. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–281. doi: 10.1212/01.WNL.0000149519.47454.F2.
    1. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. Am. J. Epidemiol. 2007;166:367–378. doi: 10.1093/aje/kwm116.
    1. Yaffe K, et al. Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study. Neurology. 2020;95:e839–e846. doi: 10.1212/WNL.0000000000010078.
    1. Bull F, Goenka S, Lambert V, et al. et al. Physical Activity for the Prevention of Cardiometabolic Disease. In: Prabhakaran D, et al., editors. Cardiovascular, Respiratory, and Related Disorders. The International Bank for Reconstruction and Development/The World Bank; 2017.
    1. Barha CK, Davis JC, Falck RS, Nagamatsu LS, Liu-Ambrose T. Sex differences in exercise efficacy to improve cognition: A systematic review and meta-analysis of randomized controlled trials in older humans. Front. Neuroendocrinol. 2017;46:71–85. doi: 10.1016/j.yfrne.2017.04.002.
    1. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: A meta-analytic study. Psychol. Sci. 2003;14:125–130. doi: 10.1111/1467-9280.t01-1-01430.
    1. Northey JM, Cherbuin N, Pumpa KL, Smee DJ, Rattray B. Exercise interventions for cognitive function in adults older than 50: A systematic review with meta-analysis. Br. J. Sports Med. 2018;52:154–160. doi: 10.1136/bjsports-2016-096587.
    1. Hachinski VC, Bowler JV. Vascular dementia. Neurology. 1993;43:2159–2160. doi: 10.1212/wnl.43.10.2159-a.
    1. Dao E, Hsiung GR, Liu-Ambrose T. The role of exercise in mitigating subcortical ischemic vascular cognitive impairment. J. Neurochem. 2018;144:582–594. doi: 10.1111/jnc.14153.
    1. Wardlaw JM, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838. doi: 10.1016/S1474-4422(13)70124-8.
    1. Wallin A, et al. Update on vascular cognitive impairment associated with subcortical small-vessel disease. J. Alzheimer's Dis. JAD. 2018;62:1417–1441. doi: 10.3233/JAD-170803.
    1. Gouw AA, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: Post-mortem quantitative MRI and neuropathology. Brain J. Neurol. 2008;131:3286–3298. doi: 10.1093/brain/awn265.
    1. Fernando MS, et al. White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391–1398. doi: 10.1161/01.STR.0000221308.94473.14.
    1. Skrobot OA, et al. Vascular cognitive impairment neuropathology guidelines (VCING): The contribution of cerebrovascular pathology to cognitive impairment. Brain J. Neurol. 2016;139:2957–2969. doi: 10.1093/brain/aww214.
    1. Jokinen H, et al. Cognitive profile of subcortical ischaemic vascular disease. J. Neurol. Neurosurg. Psychiatry. 2006;77:28–33. doi: 10.1136/jnnp.2005.069120.
    1. Gorelick PB, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–2713. doi: 10.1161/STR.0b013e3182299496.
    1. Liu-Ambrose T, et al. Aerobic exercise and vascular cognitive impairment: A randomized controlled trial. Neurology. 2016;87:2082–2090. doi: 10.1212/WNL.0000000000003332.
    1. Burzynska AZ, et al. Physical activity and cardiorespiratory fitness are beneficial for white matter in low-fit older adults. PLoS One. 2014;9:e107413. doi: 10.1371/journal.pone.0107413.
    1. Bolandzadeh N, et al. Resistance training and white matter lesion progression in older women: Exploratory analysis of a 12-month randomized controlled trial. J. Am. Geriatr. Soc. 2015;63:2052–2060. doi: 10.1111/jgs.13644.
    1. Suo C, et al. Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise. Mol. Psychiatry. 2016;21:1645. doi: 10.1038/mp.2016.57.
    1. Barha CK, et al. Sex difference in aerobic exercise efficacy to improve cognition in older adults with vascular cognitive impairment: Secondary analysis of a randomized controlled trial. J. Alzheimer's Dis. JAD. 2017;60:1397–1410. doi: 10.3233/JAD-170221.
    1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–436. doi: 10.1016/s1474-4422(02)00190-4.
    1. Laaksonen DE, et al. Physical activity in the prevention of type 2 diabetes: The Finnish diabetes prevention study. Diabetes. 2005;54:158–165. doi: 10.2337/diabetes.54.1.158.
    1. Kelley GA, Kelley KS, Tran ZV. Exercise, lipids, and lipoproteins in older adults: A meta-analysis. Prev. Cardiol. 2005;8:206–214. doi: 10.1111/j.0197-3118.2005.03769.x.
    1. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: The evidence. CMAJ Can. Med. Assoc. J. de l'Association medicale canadienne. 2006;174:801–809. doi: 10.1503/cmaj.051351.
    1. Johnson JL, et al. Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise) Am. J. Cardiol. 2007;100:1759–1766. doi: 10.1016/j.amjcard.2007.07.027.
    1. LaMonte MJ, et al. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: A prospective study of men and women. Circulation. 2005;112:505–512. doi: 10.1161/CIRCULATIONAHA.104.503805.
    1. Stewart KJ, et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am. J. Prev. Med. 2005;28:9–18. doi: 10.1016/j.amepre.2004.09.006.
    1. Verdelho A, et al. Physical activity prevents progression for cognitive impairment and vascular dementia: Results from the LADIS (Leukoaraiosis and Disability) study. Stroke. 2012;43:3331–3335. doi: 10.1161/STROKEAHA.112.661793.
    1. Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 2007;32:76–88. doi: 10.1139/h06-113.
    1. Li SS, et al. Correlation study of Framingham risk score and vascular dementia: An observational study. Medicine (Baltimore) 2017;96:e8387. doi: 10.1097/MD.0000000000008387.
    1. Liu-Ambrose T, et al. Promotion of the mind through exercise (PROMoTE): A proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol. 2010;10:14. doi: 10.1186/1471-2377-10-14.
    1. Erkinjuntti T, et al. Research criteria for subcortical vascular dementia in clinical trials. J. Neural Transm. Suppl. 2000;59:23–30. doi: 10.1007/978-3-7091-6781-6_4.
    1. Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x.
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J. Clin. Epidemiol. 2005;58:595–602. doi: 10.1016/j.jclinepi.2004.10.018.
    1. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N. Engl. J. Med. 1995;332:556–561. doi: 10.1056/NEJM199503023320902.
    1. Podsiadlo D, Richardson S. The timed "Up & Go": A test of basic functional mobility for frail elderly persons. J. Am. Geriatr. Soc. 1991;39:142–148. doi: 10.1111/j.1532-5415.1991.tb01616.x.
    1. Yesavage JA. Geriatric depression scale. Psychopharmacol. Bull. 1988;24:709–711.
    1. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): Evidence for validity. J. Clin. Epidemiol. 1999;52:643–651. doi: 10.1016/S0895-4356(99)00049-9.
    1. Miyake A, et al. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: A latent variable analysis. Cogn. Psychol. 2000;41:49–100. doi: 10.1006/cogp.1999.0734.
    1. Lezak MD. Neuropsychological Assessment. 3. Oxford University Press; 1995.
    1. Wechsler D. Wechsler Adult Intelligence Scale-III. Psychological Corporation; 1997.
    1. Spreen O, Strauss E. A Compendium of Neurological Tests. 2. Oxford University Press Inc; 1998.
    1. Trenerry M, Crosson B, DeBoe J, Leber W. Stroop Neuropsychological Screening Test. Psychological Assessment Resources; 1988.
    1. D'Agostino RB, Sr, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743–753. doi: 10.1161/CIRCULATIONAHA.107.699579.
    1. Harrison SL, et al. Cardiovascular disease risk models and longitudinal changes in cognition: A systematic review. PLoS One. 2014;9:e114431. doi: 10.1371/journal.pone.0114431.
    1. Enright PL, et al. The 6-min walk test: A quick measure of functional status in elderly adults. Chest. 2003;123:387–398. doi: 10.1378/chest.123.2.387.
    1. Borg G. Ratings of perceived exertion and heart rates during short-term cycle exercise and their use in a new cycling strength test. Int. J. Sports Med. 1982;3:153–158. doi: 10.1055/s-2008-1026080.
    1. Phillips SA, Mahmoud AM, Brown MD, Haus JM. Exercise interventions and peripheral arterial function: Implications for cardio-metabolic disease. Prog. Cardiovasc. Dis. 2015;57:521–534. doi: 10.1016/j.pcad.2014.12.005.
    1. Hughes TF, et al. Exercise and the risk of mild cognitive impairment: Does the effect depend on vascular factors? Alzheimer Dis. Assoc. Disord. 2020 doi: 10.1097/WAD.0000000000000410.
    1. Reljic D, Frenk F, Herrmann HJ, Neurath MF, Zopf Y. Low-volume high-intensity interval training improves cardiometabolic health, work ability and well-being in severely obese individuals: A randomized-controlled trial sub-study. J. Transl. Med. 2020;18:419. doi: 10.1186/s12967-020-02592-6.
    1. Mattioni Maturana F, Martus P, Zipfel S, Andreas MNI. Effectiveness of HIIE versus MICT in improving cardiometabolic risk factors in health and disease: A meta-analysis. Med. Sci. Sports Exerc. 2021;53:559–573. doi: 10.1249/MSS.0000000000002506.
    1. Hansen D, et al. Exercise prescription in patients with different combinations of cardiovascular disease risk factors: A consensus statement from the EXPERT working group. Sports Med. 2018;48:1781–1797. doi: 10.1007/s40279-018-0930-4.
    1. Kemmler W, Kohl M, von Stengel S, Schoene D. Effect of high-intensity resistance exercise on cardiometabolic health in older men with osteosarcopenia: The randomised controlled Franconian Osteopenia and Sarcopenia Trial (FrOST) BMJ Open Sport Exerc. Med. 2020;6:e000846. doi: 10.1136/bmjsem-2020-000846.
    1. Heiland EG, et al. Cardiovascular risk burden and future risk of walking speed limitation in older adults. J. Am. Geriatr. Soc. 2017;65:2418–2424. doi: 10.1111/jgs.15158.
    1. Barha CK, Liu-Ambrose T. Sex differences in exercise efficacy: Is midlife a critical window for promoting healthy cognitive aging? FASEB J. 2020;34:11329–11336. doi: 10.1096/fj.202000857R.
    1. Pandey A, et al. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: The Cooper Center Longitudinal Study. Am. Heart J. 2015;169:290–297. doi: 10.1016/j.ahj.2014.10.017.
    1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819–828. doi: 10.1016/S1474-4422(11)70072-2.
    1. Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can. Fam. Physician. 2011;57:417–423.
    1. Kivipelto M, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. Lancet Neurol. 2006;5:735–741. doi: 10.1016/S1474-4422(06)70537-3.
    1. Mitnitski A, et al. A vascular risk factor index in relation to mortality and incident dementia. Eur. J. Neurol. 2006;13:514–521. doi: 10.1111/j.1468-1331.2006.01297.x.
    1. Klages JD, Fisk JD, Rockwood K. APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2005;20:292–297. doi: 10.1159/000088317.
    1. Qiu C, Xu W, Winblad B, Fratiglioni L. Vascular risk profiles for dementia and Alzheimer's disease in very old people: A population-based longitudinal study. J. Alzheimer's Dis. JAD. 2010;20:293–300. doi: 10.3233/JAD-2010-1361.
    1. Norris CM, et al. State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender. J. Am. Heart Assoc. 2020;9:e015634. doi: 10.1161/JAHA.119.015634.

Source: PubMed

3
구독하다